People

The IPP-Trials is headed by Dr. G. Bauman (Radiation Oncologist, Chair, Department of Oncology and Director of Research, London Regional Cancer Program).  Investigators at four sites will participate in the development of this Platform:

• University Health Network (UHN)
• Sunnybrook Health Sciences Centre (SHSC)
• McMaster/Hamilton Health Sciences Centre (McMaster)
• London Health Sciences Centre (LRCP/RRI)

Project Leaders:

• See Research Areas.

Clinical user network/Advisors:

• McMaster: Karen Gulencyhn, Troy Farncombe
• SHSC: Martin Yaffe, Kathleen Pritchard
• UHN: Masoom Haider
• LRCP/RRI: Glenn Bauman, Elaine O’Riordan, Roya Etemad-Rezai, Cesare Romagnoli, Eric Winquist
  

Clinical Trial Cooperative Group Partners:

• NCI-CTG: Dr. Ralph Meyer
• OCOG: Dr. Mark Levine
• PMH NCI Phase II Consortium: Dr. Malcom Moore

More about IPP-Trials:

• Introduction
• Overview
• Research Areas